Publications
- The impact of standard chemotherapy on miRNA signature in plasma in AML patients2015 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia patients - worldwide battlefield2015 | Faculty of Medicine in Pilsen
- Discontinuation of biological therapy with tyrosine kinase inhibitors in chronic myeloid leukemia patients2014 | Faculty of Medicine in Pilsen
- Spontaneous Remission of Acute Myeloid Leukemia – a Single Center Case Reports2013 | Central Library of Charles University
- Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia2012 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Successful peripheral blood stem cells collection in a patient with nilotinib treated chronic myeloid leukemia. patient2010 | Central Library of Charles University
- Successful peripheral blood stem cells collection in imatinib pretreated and nilotinib-treated chronic myeloid leukemia patient2010 | Faculty of Medicine in Pilsen
- Successful peripheral blood stem cells collection in a patient with nilotinib treated chronic myeloid leukemia. patient2010 | Faculty of Medicine in Pilsen
- Successful peripheral blood stem cells collection in imatinib pretreated and nilotinib-treated chronic myeloid leukemia patientPublication without faculty affiliation
- Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients2023 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Second Faculty of Medicine
Loading network view...